Amy Christina Curran

Title: Amy Christina Curran: Innovator in Lipid Accumulation Technologies

Introduction

Amy Christina Curran is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the area of lipid accumulation. With a total of three patents to her name, her work focuses on enhancing the properties of acyltransferase proteins.

Latest Patents

Curran's latest patents include "Enhanced acyltransferase polynucleotides, polypeptides and methods of use" and "Acyltransferase polynucleotides, polypeptides and methods of use." The first patent provides modified DGAT1 proteins that exhibit enhanced activity without reduced protein accumulation when expressed in cells. These modified proteins can increase cellular lipid accumulation and modify the cellular lipid profile. The second patent introduces a novel DGAT1 protein with improved properties over known DGAT proteins, particularly those derived from plants. This novel protein can also be expressed in cells to achieve higher levels of lipid accumulation compared to other tested plant DGAT1 proteins.

Career Highlights

Throughout her career, Amy has worked with notable organizations such as Agresearch Limited and the National Research Council of Canada. Her innovative research has positioned her as a key figure in the development of technologies aimed at improving lipid profiles in various applications.

Collaborations

Some of her notable coworkers include Nicholas John Roberts and Somrutai Winichayakul. Their collaborative efforts have contributed to the advancement of research in lipid accumulation technologies.

Conclusion

Amy Christina Curran's work in the field of biotechnology has led to significant advancements in lipid accumulation technologies. Her innovative patents and collaborations highlight her impact on the industry.